| Literature DB >> 33367577 |
Qingyu Shi1,2, Dandan Yin1,2, Renru Han1,2, Yan Guo1,2, Yonggui Zheng1,2, Shi Wu1,2, Yang Yang1,2, Shirong Li3, Rong Zhang4, Fupin Hu1,2.
Abstract
This is the first report of ceftazidime-avibactam resistance caused by the blaKPC-33 mutation through the D179Y variant during the treatment of blaKPC-2-positive Klebsiella pneumoniae-related infections in China. The blaKPC-33-containing K. pneumoniae was susceptible to meropenem-vaborbactam, cefepime-zidebactam, tigecycline, and polymyxin B. The blaKPC-33 gene was located on a 77 551-bp transformable plasmid harboring qnrS1 and blaLAP-2. Detecting blaKPC-33-positive K. pneumoniae clinical strains is important for infection control.Entities:
Keywords: zzm321990 blazzm321990 KPC-2zzm321990 ; zzm321990 blazzm321990 KPC-33zzm321990 ; Carbapenem-resistant K. pneumoniae; Ceftazidime-avibactam; Meropenem-vaborbactam
Year: 2020 PMID: 33367577 DOI: 10.1093/cid/ciaa1521
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079